Stocks Health care WINT
OTC · Health careWindtree Therapeutics Inc (WINT)
It posted a net loss of $40M. In fiscal 2024 capital spending exceeded operating cash flow by $15.4M. At September 30, 2025 it held $204K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 19, 2025.
Watch WINT in 60 secondsWhat Windtree Therapeutics Inc does
Windtree Therapeutics Inc is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on OTC under the ticker WINT.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2024 | n/a | -$1.8M | -$104.35 | -$15.4M |
| 2023 | n/a | -$20.3M | -$4,718.84 | -$13.5M |
| 2022 | n/a | -$39.2M | -$56,040.73 | -$19.5M |
| 2021 | n/a | -$67.6M | -$2,458.48 | -$23.9M |
| 2020 | n/a | -$32.6M | -$1,873.13 | -$25.6M |
| 2019 | $198K | -$27.5M | -$2,260.36 | -$24.9M |
Full financial statements: income, balance sheet and cash flow
Dividends
It paid out $657K in cash dividends.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2024 | n/a | $657K | n/a |
| 2023 | n/a | $0 | n/a |
Latest SEC filings
What Windtree Therapeutics Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- July 22, 2026
- April 1, 2026Late annual report notice NT 10-K
- January 7, 2026
- December 2, 2025New debt 8-K
- November 21, 2025
- November 19, 2025
- November 14, 2025Late quarterly report notice NT 10-Q
- November 13, 2025
- October 24, 2025IPO registration S-1
- October 16, 2025New debt 8-K
Questions about WINT
What does Windtree Therapeutics Inc do?
Windtree Therapeutics Inc is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on OTC under the ticker WINT.
Is Windtree Therapeutics Inc profitable?
No. Over the twelve months to September 30, 2025 it reported a net loss of $40M.
When did Windtree Therapeutics Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 19, 2025. It covers the period to September 30, 2025. Its newest filing of any kind is the material agreement from July 22, 2026.
Similar companies
Compare WINT with
Follow WINT
Get an email when Windtree Therapeutics Inc files with the SEC: results, executive changes, material agreements and annual reports.
Follow WINT: get an email when it filesWhere the numbers come from
Financial figures are the values Windtree Therapeutics Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.